Clinical Trial Update: Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the effect of resveratrol on age-related insulin resistance and inflammation in humans completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Type 2 Diabetes Mellitus

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Type 2 Diabetes Mellitus, Insulin Resistance | Phase 2 | Status: COMPLETED | Results posted: 2022-03-08